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therefore, makes segmentation of different heart structures 
feasible in the clinic.  
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Purpose/Objective: There is an increasing tendency to 
consider axillary radiotherapy (AR) in preference to axillary 
node clearance (ANC) in early breast cancer following the 
recent results of the AMAROS trial which demonstrated 
equivalent local control but reduced arm lymphoedema after 
AR. Consequently AR is permissible within the POSNOC trial 
(evaluating the role of axillary treatment in women with 
early stage breast cancer and one or two sentinel node 
macrometastases).  
We set out to quantify axillary radiotherapy in terms of field 
placement and dose in UK radiotherapy centres participating 
in POSNOC.  
Materials and Methods: Data was collected from dummy run 
cases submitted as part of the POSNOC radiotherapy quality 
assurance programme and reviewed using radiotherapy plan 
visualisation software (VODCA). Anatomical points relative to 
the axillary nodal boundaries identified by RTOG (Radiation 
Therapy Oncology Group) within the Breast Cancer Atlas for 
Radiation Therapy Planning were defined to evaluate axillary 
field placement and dose to the axillary nodes at depth.  
• Field placement was assessed measuring the 50% isodose 
relative to the superior (cricoid cartilage), lateral (medial 
border of latissimus dorsi) and medial (trachea-midpoint 
cranial of the base of clavicle caudal of thyroid) extent of the 
axillary nodal boundaries.  
• Dose to the axillary nodal levels at depth was assessed by 
measuring a point dose at the posterior aspect of the 
midpoint of the cranial-caudal and lateral-medial extent of 
each nodal level boundary. 
Results: Figure 1: 
 
 
 
Conclusions: The results suggest that treatment fields 
encompass the axillary nodal boundaries in the superior and 
lateral dimensions irrespective of planning approach. 
However, there is a potential compromise regarding the 
coverage of the medial nodal boundary, with some cases not 
encompassing the complete medial extent proximal to the 
trachea. Comparing volume with field based techniques 
suggests that coverage of the medial supraclavicular nodes is 
optimised when adopting a volumetric planning approach. 
The POSNOC radiotherapy guidelines recommend that ≥ 80% 
of the prescribed dose is achieved at mid-axilla and that the 
dose to the supraclavicular fossa nodes should be >90% of the 
prescribed dose. The point dose results suggest that each 
method of prescribing and/or beam arrangement for axillary 
nodal radiotherapy can achieve these dose levels, but in 
some cases level 1 nodes received less than 75% of the 
prescribed dose. The evaluation of anatomical reference 
points represents a simple method for evaluating axillary 
nodal coverage for centres not using a volumetric planning 
approach.  
POSNOC is funded by the National Institute for Health 
Research Health Technology Assessment (NIHR HTA) 
Programme-12/35/17. 
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Purpose/Objective: In our clinic breast cancer patients who 
receive locoregional treatment are positioned on a CQual 
breastboard (CIVCO, USA). This set-up leaves room for 
inaccuracies, especially in the area of the cervical vertebrae.  
The aim of this study is to determine whether fixation of the 
chin improves the stability of the supraclavicular lymph node 
area. 
Materials and Methods: 
 
 
Figure 1: chin fixation 
In April 2014 chin fixation was introduced in our department 
for patients that receive locoregional radiotherapy for breast 
cancer. This chin fixation is made using posicast 
thermoplastic mask material (Macromedics, the Netherlands) 
and is attached to the breastboard (figure 1). 
To evaluate the potential benefit of chin fixation, a 
comparison was made between two groups of patients 
positioned without/with chin fixation. The two groups 
contained the last 13 patients before introducing chin 
fixation and the first 13 patients with chin fixation. The 
group without chin fixation was given verbal instruction by 
RTTs to turn the chin 45 degrees to the contralateral side. 
For both patient groups IGRT is performed on daily basis or 
once a week, dependent of the IGRTprotocol, using Cone-
Beam CT (CBCT) imaging.  
Clinically the correction of the patient set-up was based on 
registration of the chest wall/sternum using a bone match 
algorithm in XVI. 80 CBCTs per group with an average of 6 
CBCTs per patient were used for this study.  
The number of CBCTs ranged between 3 and 11 per patient. 
The stability of the supraclavicular lymph node area is 
defined as the change of position with respect to the chest 
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wall/sternum. It is determined by calculating the difference 
between registration results of the two areas, both for 
translations and rotations. For registration of the 
supraclavicular lymph node area the trachea was used as a 
surrogate. Registration of this area was performed using a 
grey-value algorithm.  
The systematic and random error and group mean of the 
lymph node position was calculated for both groups. T-test 
was performed to determine significant difference between 
the mean of both groups. 
Results: 
 
Results are presented in table 1.  
This study shows no significant differences between the set-
up accuracy of both groups. 
The systematic translation error in the cranial-caudal 
translation is the largest for both patient groups. 
The systematic error of the left-right, cranial-caudal and 
anterior-posterior rotations didn't show a significantly smaller 
rotational error in the supra clavicular area for the group 
with the chin fixation. 
Conclusions: The addition of chin fixation doesn't improve 
the stability of the supraclavicular lymph node area, nor does 
it prevent great deviations in individual patient set-up. 
Limitations of the current study could be the small sample 
size, the learning curve in the fabrication of the chin fixation 
and its use.  
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Purpose/Objective: External radiotherapy after surgery is 
considered standard for breast conserving treatment. In some 
patients, boost over the breast region at risk for local 
recurrences can be administered sequentially or concomitant 
(simultaneous integrated boost: SIB) with whole breast 
irradiation. This SIB technique reduces the total time of 
treatment and sometimes determines best dose 
homogeneity. Acute cutaneous toxicity is due to the 
cumulative dose and dose per fraction administered, so it can 
be thought that SIB increases this side-effect.  
Our objective was to evaluate acute skin toxicity in 
radiotherapy breast cancer and differences between 
concomitant and sequential boost. 
Materials and Methods: We analyzed 160 patients with 
breast conserving treatment, aged from 33 to 80 years. 
Radiation treatment was delivered with Linear Accelerator 
and 3D-planning. Planning Target Volumes and doses were: 
PTV1: 50Gy whole breast + PTV2 (boost): 10-14Gy with two 
different techniques: sequential or concomitant (SIB). 
Skin toxicity was assessed weekly using the RTOG scale. 
Results: Radiation boost: SIB was applied in 65 patients 
(40.3%); Sequential boost in 95 patients (59.75%) 
Skin Toxicity : Global Grade I radiodermitis was evaluated in 
86 patients (54.1%); Grade II in 72 patients (45.3%); Grade III 
only in 1 patient (0.61%) 
According to the boost technique: (fig.1) 
-SIB: Gr I, 38 pts (58.4% of this group); Gr II, 27 pts (41.5%). 
No grade III toxicity was assessed. 
-Sequential boost: Gr I, 48pts (50.5% of this group); Gr II/III, 
47 pts (49.4%) 
Differences in grade I toxicity SIB vs sequential were not 
statistically significant: p=0.41; and differences in grade 
II/III, neither were statistically significant: p=0.27 
 
Fig.1. RTOG toxicity and boost technique 
 
Conclusions: In our Institution, acute skin toxicity in external 
radiotherapy with boost for breast cancer is mild, with less 
than 1% of grade III complications.  
There are a greater number of patients with grade I and 
grade II/III in sequential boost vs SIB, but these differences 
were not statistically significant so we can conclude that 
Simultaneous Integrated Boost does not increase acute 
cutaneous toxicity, and reduces the overall duration of 
treatment.  
One more in-depth analysis of the data and other parameters 
(irradiated volume, dosimetry,…) could confirm this results or 
stablish differences in toxicity between these two 
techniques. 
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Purpose/Objective: Most local recurrences occur in or near 
the tumor bed after breast-conserving therapy (lumpectomy 
followed by whole breast irradiation (WBRT)). Tracking the 
boost volume instead of the thoracic wall using implanted 
surgical clips might reduce RT planning margins. In this study, 
the accuracy of surgical clip matching on conebeam CT 
(CBCT) and the relative motion of the clip area relative to 
the thoracic wall was investigated. 
Materials and Methods: The accuracy of the clip matching 
was studied by determination of the interobserver variation 
using the standard deviation of the X, Y and Z-direction in all 
matches. In a group of 20 breast cancer patients, 5 to 8 
CBCT's were acquired (128 scans in total). During surgery 2 to 
5 clips were implanted with a median of 4 clips per patient. 
Each CBCT was registered by 3 or 4 Radiation Therapy 
Technicians (RTTs) to the planning CT in XVI software (Elekta 
AB) resulting in 484 independent registrations (on average 3.8 
per scan). For registration, a clipbox encompassing the clips 
area was defined. Next, the automatic seed match option 
